Waddington, C., Walker, W., Oeser, C., Reiner, A., John, T., Wilkins, S., . . . Pollard, A. (2010). Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: Open label, randomised, parallel group, multicentre study.
Chicago-čujuhus (17. p.)Waddington, C., et al. Safety and Immunogenicity of AS03B Adjuvanted Split Virion Versus Non-adjuvanted Whole Virion H1N1 Influenza Vaccine in UK Children Aged 6 Months-12 Years: Open Label, Randomised, Parallel Group, Multicentre Study. 2010.
MLA-čujuhus (9. p.)Waddington, C., et al. Safety and Immunogenicity of AS03B Adjuvanted Split Virion Versus Non-adjuvanted Whole Virion H1N1 Influenza Vaccine in UK Children Aged 6 Months-12 Years: Open Label, Randomised, Parallel Group, Multicentre Study. 2010.